Studies on the pathology, especially brain hemorrhage and angioendotheliomas, induced by two new mos-containing viruses

References

• Alroy L., Goyal V., Skutelsky E. Lectin histochemistry of mammalian endothelium. Histochemistry 1987; 86: 603–607
   PubMedGoogle Scholar
• Belloni P. N., Tressler R. J. Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells. Cancer Metastasis Rev 1990; 8: 353–389
   Google Scholar
• Bold R. J., Donoghue D. J. Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors. Mol Cell Biol 1985; 5: 3131–3138
   PubMedGoogle Scholar
• Carroll J. T., Jr, Schelper R. L., Goeken J. A., Kemp J. D. Neoplastic angioendotheliomatosis: immunopathologic and morphologic evidence for intravascular malignant lymphomatosis. Am J Clin Pathol 1986; 85: 169–175
   PubMed Web of Science ®Google Scholar
• Coffin J. D., Harrison J., Schwartz S., Heimark R. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dey Biol 1991; 148: 51–62
   PubMedGoogle Scholar
• Hayashi Y., Tange T., Urano Y., Smadja-Joffe F., Le Bousse-Kerdiles M. C., Jasmin C. Histopathologic studies on myeloproliferative sarcoma virus (MPLSV) induced leukemias and hemangiosarcoma in Jar-2 rats. Pathol Res Pract 1988; 183: 314–320
   Google Scholar
• Hilberg F., Stocking C., Ostertag W., Grez M. Functional anlaysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci USA 1987; 84: 5232–5236
   PubMedGoogle Scholar
• Kennedy M. T., Brockman H., Rusnak F. Contributions of myristoylation to calcineurin structure/function. J Biol Chum 1996; 271: 26517–26521
   PubMed Web of Science ®Google Scholar
• Knighton D. R., Zheng J., Ten Eyck L. F., Ashford V. A., Xuong N. H., Taylor S. S., Sowadski J. M. Crystal structure of the catalytic subject of cyclic: adenosine monophospliale-dependent protein kinase. Science 1991; 253: 407–414
   PubMed Web of Science ®Google Scholar
• Laitinen L. Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 1987; 19: 225–234
   PubMedGoogle Scholar
• Mann R., Mulligan R. C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153–159
   PubMed Web of Science ®Google Scholar
• Maxwell S. A., Arlinghaus R. B. Serine kinase activity associated with Moloney murine sarcoma virus-124-encoded p37mos. Virology 1985; 143: 321–333
   PubMed Web of Science ®Google Scholar
• Moloney J. B. A virus-induced rhabdomyosarcoma of mice. Natl Cancer Inst Monogr 1966; 22: 139–142
   PubMedGoogle Scholar
• Propst F., Cork L. C., Kovatch R. M., Kasenally A. B., Wallace R., Rosenberg M. P. Progressive hind limb paralysis in mice carrying a v-Mos transgene. J Neuroputhol Exp Neurol 1992; 51: 499–505
   Google Scholar
• Propst F., Rosenberg M. P., Cork L. C., Kovatch R. M., Ranch S., Westphal H., Khillan J., Schulz N. T., Neumann P. E., Newmann P. E. Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene. Proc Natl Acad Sci USA 1990; 87: 9703–9707, ‘published erratum app ears in Proc Natl Acad Sci USA 1991 May 1’; 88(9):4060
   PubMedGoogle Scholar
• Ribacchi R., Giraldo G. Plasmacytomas occurring in the bones of rats injected intracerebrally with murine sarcoma virus (MSV), Moloney' strain. Preliminary report. Lav 1st Anat Istol Patol Perugia 1966; 26: 149–156
   Google Scholar
• Robertson S. C., Donoghue D. J. Identification of an autoinhibitory region in the activation loop of the Mos protein kinase. Mol Cell Biol 1996; 16: 3472–3479
   PubMedGoogle Scholar
• Sahagun G., Moore S. A., Fabry Z., Schelper R. L., Hart M. N. Purification of murine endothelial cell cultures by flow cytometry using fluoreseein-labeled griffonia simplicifolia agglutinin. Am J Pathol 1989; 134: 1227–1232
   PubMed Web of Science ®Google Scholar
• Singh B., Stocking C., Walker R., Yang Y. D., Ostertag W., Arlinghaus R. B. v-mos proteins encoded by myeloproliferative sarcoma virus and its tsl59 mutant. J Virol 1992; 66: 1267–1272
   PubMedGoogle Scholar
• Singh B., Hannink M., Donoghue D. J., Arlinghaus R. B. p37mos-assoeiated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. J Virol 1986; 60: 1148–1152
   PubMedGoogle Scholar
• Slice L. W., Taylor S. S. Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli. J Biol Cham 1989; 264: 20940–20946
   PubMedGoogle Scholar
• Stacey A., Arbuthnott C., Kollek K., Coggins L., Osterlag W. Comparison of myeloproliferative sarcoma virus with moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis. J Virol 1984; 50: 725–732
   PubMedGoogle Scholar
• Stanton M. F., Law L. W., Ting R. G. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies. J Natl Cancer Inst 1968; 40: 1113–1129
   Google Scholar
• Slocking C., Kollek R., Bergholz U., Ostertag W. Long terminal repeal sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma viruses. Proc Null Acad Sci USA 1985; 82: 5746–5750
   Google Scholar
• Stocking C., Kollok R., Bergholz U., Ostertag W. Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus. Virology 1986; 153: 145–149
   PubMedGoogle Scholar
• Stoica G., Hoffman J., Yuen P. H. Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in BALB/c mice. Am J Pathol 1990; 136: 933–947
   Google Scholar
• Taylor S. S., Radzio-Andzelm E. Three protein kinase structures define a common motif. Structure 1994; 2: 345–355
   PubMedGoogle Scholar
• Toda K., Tsujioka K., Maruguchi Y., Ishii K., Miyachi Y., Kuribayashi K., Imamura S. Establishment and characterization of a tumorigenic murine vascular endothelial cell line (F-2). Cancer Res 1990; 50: 5526–5530
   Google Scholar
• Van Beveren C., van Straaten F., Galleshaw J. A., Verma I. M. Nucleotide sequence of the genome of a murine sarcoma virus. Cell 1981; 27: 97–108
   PubMed Web of Science ®Google Scholar
• Vinores S. A., Herman M. M., Perentes E., Nakagawa Y., Thomas C. B., Innes D. J., Rubinstein L. J. The growth of two murine hemangioendotheliomas intra-cranially, subcutaneously, and in culture, and their comparison with human cerebellar hemangioblastomas: morphological and immunohislochemical studies. Acta Nerunpathol 1992; 84: 67–77
   Google Scholar
• Wong P. K., Soong M. M., Yuen P. H. Replication of murine leukemia virus in heterologous cells: interaction between ecotropic and xenotropic viruses. Virology 1981; 109: 366–378
   PubMed Web of Science ®Google Scholar
• Yew N., Oskarsson M., Daar I., Blair D. G., Vande Woude G. F. mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol Cellular Biol 1991; 11: 604–010
   PubMed Web of Science ®Google Scholar
• Yuen P. H., Kwak Y. T. R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in-frame truncated gag-mos gene, induces brain lesions. Virology 1997; 236: 213–218
   Google Scholar
• Yuen P. H., Kwak Y. T. Studies on the pathology, especially brain lesions, induced by R7, a spontaneous mutant of Moloney murine sarcoma virus 124. Am J Pathol 1998; 152: 1509–1520
   Google Scholar
• Yuen P. H., Khang Y. H., Kumar A., Szurek P. F., Maull E. A. The Moloney murine leukemia virus enhancer and its flanking sequences collaborate to deter mine virulence in T-cell lymphomagenesis. Mol Carcinog 1991a; 4: 72–80
   Google Scholar
• Yuen P. H., Matherne C. M., Molinari-Storey L. M. SV7, a molecular clone of Moloney murine sarcoma virus 349, transforms vascular endothelial cells. Am J Pathol 1991b; 139: 1449–1461
   Google Scholar
• Yuen P. H., Szurek P. F. The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV.-TB is mapp ed to 11 mutations within the U3 region of the long terminal repeal. J Virol 1989; 63: 471–480
   PubMed Web of Science ®Google Scholar